Rohto Pharmaceutical Co.,Ltd.

4527.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income¥31¥31¥34¥28
Dep. & Amort.¥13¥9¥8¥8
Deferred Tax¥0¥0¥0¥0
Stock-Based Comp.¥0¥0¥0¥0
Change in WC-¥6-¥9-¥11¥0
Other Non-Cash-¥1¥3¥0-¥9
Operating Cash Flow¥37¥34¥31¥27
Investing Activities
PP&E Inv.-¥11-¥8-¥10-¥11
Net Acquisitions¥32¥0-¥2-¥1
Inv. Purchases-¥10-¥9-¥6-¥6
Inv. Sales/Matur.¥6¥2¥3¥2
Other Inv. Act.-¥107-¥1¥2-¥0
Investing Cash Flow-¥89-¥16-¥13-¥16
Financing Activities
Debt Repay.¥32-¥1-¥10¥8
Stock Issued¥0¥0¥0¥0
Stock Repurch.-¥5¥0¥0¥0
Dividends Paid-¥7-¥5-¥5-¥3
Other Fin. Act.¥15-¥7-¥2-¥1
Financing Cash Flow¥35-¥14-¥16¥3
Forex Effect¥3¥5¥5¥4
Net Chg. in Cash-¥13¥9¥7¥19
Supplemental Information
Beg. Cash¥87¥78¥71¥52
End Cash¥73¥87¥78¥71
Free Cash Flow¥28¥25¥21¥16